International Standard Compliance: ISO 13485 & ISO 11608-1 Quality and safety are the foundation of our manufacturing process
But remember: Mounjaro has significantly more evidence base, while Retatrutide data is based on smaller studies
If youre not breastfeeding, your physician might discuss restarting treatment earlier
Advise patients that substantial or rapid weight loss can increase the risk of gallbladder disease, but that gallbladder disease may also occur in the absence of substantial or rapid weight loss
A persons eligibility for GLP-1 weight loss treatment is determined by specific medical criteria, primarily related to their Body Mass Index (BMI)
For the subgroup analysis of the time to the first occurrence of the main 5-component composite endpoint, the pre-specified Cox regression model also included an interaction between treatment group and the subgroup of interest, with the interaction P values evaluated using a score test